Independent Director Director Since: 2019 Age: 50 Committee Service: Audit (Chair) Professional Experience: Managing Partner, Life Sciences Advisory, LLC (2009 present) Investment Banker, Merrill Lynch & Co., Inc. (1999 2009) Financial Analyst, Wasserstein Perella & Co. (1997 1998) Education: B.A., Economics, Stanford University M.S., Management Science and Engineering, Stanford University M.Phil., Management Studies, University of Cambridge Other Public Company Boards: Mirum Pharmaceuticals, Inc. (2022 present) Day One Biopharmaceuticals, Inc. (2021 present) Glenmark Pharmaceuticals, Ltd (2019 present) Akouos, Inc. (2020 2022) Sangamo Therapeutics, Inc. (2012 2022) Innovate Biopharmaceuticals, Inc. (2018 2020) Cassava Sciences, Inc. (2013 2020) Repros Therapeutics Inc. (2013 2018) Other Affiliations: Guest lecturer for the Bioscience Enterprise Programme, University of Cambridge Health Innovator Fellow, Aspen Institute, and Member, Aspen Global Leadership Network The Nominating and Corporate Governance Committee and Board believe Ms. Ramasastry is qualified to serve on the Board due to her extensive experience in global healthcare investment banking and strategic advisory consulting in the life sciences industry.